Mkt Cap$2.13T-0.07%
24h Vol$108.35B
BTC Dom55.7%
ETH Dom8.8%
F&G12Extreme Fear
BTC$59,122.00-1.06% ETH$1,558.70-1.78% USDT$0.9986+0.00% BNB$553.00-0.29% USDC$0.9996-0.01% XRP$1.03-2.54% SOL$65.85-0.94% TRX$0.3235-0.67% FIGR_HELOC$1.03-0.49% HYPE$61.33+2.82% DOGE$0.0734-1.03% USDS$0.9996+0.00% RAIN$0.0157-0.45% LEO$9.35-0.70% ZEC$396.61-0.83% XLM$0.1764-4.24% BTC$59,122.00-1.06% ETH$1,558.70-1.78% USDT$0.9986+0.00% BNB$553.00-0.29% USDC$0.9996-0.01% XRP$1.03-2.54% SOL$65.85-0.94% TRX$0.3235-0.67% FIGR_HELOC$1.03-0.49% HYPE$61.33+2.82% DOGE$0.0734-1.03% USDS$0.9996+0.00% RAIN$0.0157-0.45% LEO$9.35-0.70% ZEC$396.61-0.83% XLM$0.1764-4.24%
News

market analysis

Total Stories
1,143
Section
market analysis
Why Is Ocular Therapeutix (OCUL) Stock Up Premarket Today?
Market Analysis

Why Is Ocular Therapeutix (OCUL) Stock Up Premarket Today? Sanofi Bid Rejection Fuels Rally

Ocular Therapeutix stock jumped over 18% in premarket trading after rejecting Sanofi’s $16 per share buyout offer, as investors turned bullish on the company’s late-stage pipeline.

Tim FriesJan 15, 20263 min read